No increase in acute kidney injury risk for SGLT2 users
(HealthDay)—The risk of acute kidney injury (AKI) is not increased for new sodium-glucose cotransporter-2 (SGLT2) inhibitor users, according to a study published online Aug. 21 in Diabetes Care.
Aug 24, 2017
0
0